Remission of progressive multifocal leukoencephalopathy and primary central nervous system lymphoma in an HIV-infected patient

European Journal of Neurology

Volumn 14, Issue 6, 2007, Pages 598-602

  Lima, M A ^c,d,f   Katz Brull, R ^b,e   Lenkinski, R E ^e   Nunez, R ^g   Feinrider, D ^h   Koralnik, I J ^a,c,d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Division of Viral Pathogenesis   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g Soma Medical Center   (United States)

^h JFK Medical Center   (United States)

Author keywords

Acquired immune deficiency syndrome; Human immunodeficiency virus; Lymphoma; Progressive multifocal leukoencephalopathy

Indexed keywords

DEXAMETHASONE; EFAVIRENZ; LAMIVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; CONVALESCENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; LYMPHOCYTE COUNT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTON NUCLEAR MAGNETIC RESONANCE; REMISSION; VIRUS LOAD;

ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE;

EID: 34249797313     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01820.x     Document Type: Article

References (27)

1. Cinque P, Vago L, Dahl H, et al. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996 10 : 951 958.
2. Arribas JR, Clifford DB, Fichtenbaum CJ, Roberts RL, Powderly WG, Storch GA. Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. Journal of Clinical Microbiology 1995 33 : 1580 1583.
3. Mocroft AJ, Lundgren JD, d'Armino Monforte A, et al. Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. International Journal of Epidemiology 1997 26 : 400 407.
4. Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name Ann Neurol 2006 60 : 162 173.
5. Skiest DJ, Crosby C. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma. AIDS 2003 17 : 1787 1793.
6. Gallia GL, DelValle L, Laine C, Curtis M, Khalili K. Concomitant progressive multifocal leucoencephalopathy and primary central nervous system lymphoma expressing JC virus oncogenic protein, large T antigen. Molecular Pathology 2001 54 : 354 359.
7. Du Pasquier RA, Kuroda MJ, Schmitz JE, et al. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. Journal of Virology 2003 77 : 11918 11926.
8. Skolasky RL, Dal Pan GJ, Olivi A, Lenz FA, Abrams RA, McArthur JC. HIV-associated primary CNS lymorbidity and utility of brain biopsy. Journal of the Neurological Sciences 1999 163 : 32 38.
9. Marzocchetti A, Di Giambenedetto S, Cingolani A, Ammassari A, Cauda R, De Luca A. Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. Journal of Clinical Microbiology 2005 43 : 4175 4177.
10. Giudici B, Vaz B, Bossolasco S, et al. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clinical Infectious Diseases 2000 30 : 95 99.
11. Bossolasco S, Cinque P, Ponzoni M, et al. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma. Journal of Neurovirology 2002 8 : 432 438.
12. Ivers LC, Kim AY, Sax PE. Predictive value of polymerase chain reaction of cerebrospinal fluid for detection of Epstein-Barr virus to establish the diagnosis of HIV-related primary central nervous system lymphoma. Clinical Infectious Diseases 2004 38 : 1629 1632.
13. Portegies P, Solod L, Cinque P, et al. Guidelines for the diagnosis and management of neurological complications of HIV infection. European Journal of Neurology 2004 11 : 297 304.
14. Skiest DJ. Focal neurological disease in patients with acquired immunodeficiency syndrome. Clinical Infectious Diseases 2002 34 : 103 115.
15. Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993 187 : 233 240.
16. Antinori A, De Rossi G, Ammassari A, et al. Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. Journal of Clinical Oncology 1999 17 : 554 560.
17. Port JD, Miseljic S, Lee RR, et al. Progressive multifocal leukoencephalopathy demonstrating contrast enhancement on MRI and uptake of thallium-201: a case report. Neuroradiology 1999 41 : 895 898.
18. Krishna L, Slizofski WJ, Katsetos CD, et al. Abnormal intracerebral thallium localization in a bacterial brain abscess. Journal of Nuclear Medicine 1992 33 : 2017 2019.
19. Gorniak RJ, Kramer EL, McMeeking AA, Zagzag D. Thallium-201 uptake in cytomegalovirus encephalitis. Journal of Nuclear Medicine 1997 38 : 1386 1388.
20. Chang L. In vivo magnetic resonance spectroscopy in HIV and HIV-related brain diseases. Reviews in the Neurosciences 1995 6 : 365 378.
21. Simone IL, Federico F, Tortorella C, et al. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. Journal of Neurology, Neurosurgery and Psychiatry 1998 64 : 516 523.
22. Katz-Brull R, Lenkinski RE, Du Pasquier RA, Koralnik IJ. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology 2004 63 : 897 900.
23. Chang L, Miller BL, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995 197 : 525 531.
24. Koralnik IJ, Du Pasquier RA, Kuroda MJ, et al. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. Journal of Immunology 2002 168 : 499 504.
25. Du Pasquier RA, Koralnik IJ. Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial Journal of Neurovirology 2003 9 (Suppl 1 25 31.
26. Newell ME, Hoy JF, Cooper SG, et al. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer 2004 100 : 2627 2636.
27. Behin A, Delattre JY. Complications of radiation therapy on the brain and spinal cord. Seminars in Neurology 2004 24 : 405 417.